INVESTIGATION REMINDER: Schall Law Firm Announces It is Investigating Claims Against Accelerate Diagnostics, Inc. and Encourages Investors Who Have Suffered Losses to Contact the Firm

LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights law firm, announces that it is investigating claims on behalf of investors of Accelerate Diagnostics, Inc. (“Accelerate Diagnostics” or “the company”) (NASDAQ: AXDX) for violating securities laws.

The investigation aims to determine whether the Company has made false and/or misleading statements and/or has failed to disclose relevant information to investors. Accelerate Diagnostics disclosed on October 21, 2022 that it had received a request from the FDA to immediately cease marketing and distribution of its Accelerate Arc System and associated BC Kit for particular use as a diagnostic. The FDA said the company’s products require 510(k) clearance, which the company previously thought was exempt. Based on this news, shares of Accelerate Diagnostics fell more than 41% in intraday trading on October 24, 2022.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us via the firm’s website at www.schallfirm.com or by e-mail at [email protected]

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to do nothing, you can remain an absent member of the group.

Schall Law Firm represents investors worldwide and specializes in securities class action and shareholder rights litigation.

This press release may be considered attorney advertising in certain jurisdictions under applicable law and ethical requirements.